You are viewing the site in preview mode

Skip to main content

Advertisement

Fig. 6 | BMC Infectious Diseases

Fig. 6

From: Universal test, treat, and keep: improving ART retention is key in cost-effective HIV control in Uganda

Fig. 6

Cost-effectiveness acceptability curves. a Lines show the proportion of parameter sets for which an intervention is the most cost-effective option (highest net monetary benefit), for different willingness to pay per DALY averted thresholds. Interventions which are the most cost-effective option in less than 5% of scenarios at all willingness to pay thresholds are combined into the single category ‘other’. b Lines show the proportion of parameter sets where the most cost-effective intervention includes each individual intervention component, for different willingness to pay per DALY averted thresholds. Combinations of three and four interventions were included in the analysis for Fig. 6b, but not for Fig. 6a

Back to article page